Concepedia

Publication | Closed Access

TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.

DOI

17

Citations

0

References

2019

Year

HG Zhang, Yingwei Pan, Jin Feng, Zeng Ct, Zhao Xq, B.-L. Liang, Zhang Ww
PubMed

Abstract

TRIM66 is highly expressed in HCC, which is positively correlated with tumor stage, lymph node metastasis and distant metastasis of HCC patients. In addition, TRIM66 promotes the malignant progression of HCC by inhibiting E-cadherin through the EMT pathway.